Highlighting top abstracts for the annual radiation oncology conference
The field of radiation therapy has evolved in recent years due to advances in technology and techniques. To stay ahead, radiation oncologists converge each year at the ASTRO (American Society of Radiation Oncology) annual meeting to glean the latest scientific research. To help prepare for the upcoming 2023 meeting, radiation oncology leaders from Cleveland Clinic’s Cancer Center have highlighted ten of the top abstracts of note to watch for.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Patient-Free Simulation: Analysis of Hospitalized Patients Treated without CT Simulation
Presented by Erik Davies, MD
Abstract #2215
10:45am-12:00PM PT, Monday, October 2
Hall B2
Phase II Randomized Trial of Single- vs. Two-Fraction Spine Stereotactic Radiosurgery for the Treatment of Vertebral Metastases
Presented by Cole Billena, MD
Abstract #2917
10:45AM-12:00PM PT, Monday, October 2
Hall B2
Five Fraction Accelerated Partial Breast Irradiation vs. Intraoperative Radiation Therapy for Early-Stage Breast Cancer
Presented by Ahmed Hamila, MD
Abstract #2377
3:00-4:00PM PT, Monday, October 2
Hall B2
Impact on Radiation Therapy Recommendation and Treatment Modality for Patients With Ductal Carcinoma In Situ Using the 7Gene Biosignature: Analysis of the PREDICT Study
Presented by Chirag Shah, MD
Abstract #2439
3:00-4:00PM PT, Tuesday, October 3
Hall B2
Results of a Phase I Trial of Dose Escalation for Preoperative Stereotactic Radiosurgery for Patients with Large Brain Metastases
Presented by Kailin Yang, MD, PhD
Abstract #243
2:33-2:40PM PT, Tuesday, October 3
Room 6 C/F
Local Cost-Effectiveness of Nasopharyngeal Carcinoma Screening Strategies in Southern China: Secondary Analysis of the PRO-NPC-001 Cluster-Randomized Trial
Presented by Jacob Miller, MD
Abstract #234
3:00-3:07PM PT, Tuesday, October 3
Room 1
Sema3C Signaling is an Alternative Activator of the Canonical WNT Pathway in Glioblastoma
Presented by Jennifer Yu, MD, PhD
Abstract #1120
4:05-4:10PM PT, Tuesday, October 3
Room 8
Meta-Analysis of Five Fraction Preoperative Radiotherapy for Soft Tissue Sarcoma
Presented by Zachary Mayo, MD
Abstract #1156
4:05-4:10PM PT, Tuesday, October 3
Room 5
Liver Dome Gating Using kV Triggered Imaging Reduces Dosimetric Error Caused by Breath Hold Variability for Liver Stereotactic Body Radiation Therapy
Presented by Bingqi Guo, PhD
Abstract #1288
8:30-8:35AM PT, Tuesday, October 3
Room 8
Can We Improve the Quality of Care Delivered to Cervical Cancer Patients? Development of Quality Metrics and Quality Improvement Program at a Single Institution
Presented by Sudha Amarnath, MD
Abstract #292
11:20-11:27AM PT, Wednesday, October 4
Room 2
Correlation found between the biomarker HSD3B1 and resistance to combined hormone therapy and radiotherapy
Meta-analysis suggests efficacy and safety
Transperineal ultrasound a viable, non-invasive option for monitoring intra-fractional prostate motion
Key abstracts highlight advances in treating locally advanced and refractory disease
Multidisciplinary team to examine radiation therapy combined with immunotherapy
Preoperative treatment ensures successful surgical resection
Modification of traditional staging factors associated with survival in high-risk disease
Hyperthermia, neoadjuvant chemoradiation and reconstruction hold promise of long-term survival